Publication | Closed Access

Molecular profiling of malignant peritoneal mesothelioma identifies the ubiquitin–proteasome pathway as a therapeutic target in poor prognosis tumors

OncologyMalignant DiseaseMedicineCancer Cell BiologyPathologyProtein DegradationUbiquitin–proteasome PathwayCancer GenomicsCancer BiologyCell BiologyCancer ResearchTumor BiologyPoor Prognosis TumorsMolecular Profiling